Recombinant Mammaglobin A Adenovirus-Infected Dendritic Cells Induce Mammaglobin A-Specific CD8+ Cytotoxic T Lymphocytes against Breast Cancer Cells In Vitro

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Cui, Huixia ^a,b   Zhang, Wenlu ^b   Hu, Wei ^a   Liu, Kun ^b   Wang, Tong ^a   Ma, Nan ^a   Liu, Xiaohui ^a   Liu, Yunpeng ^a   Jiang, Youhong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MAMMAGLOBIN A; TUMOR NECROSIS FACTOR ALPHA; IL10 PROTEIN, HUMAN;

ADENOVIRUS; ADULT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL KILLING; CELL MATURATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY; UPREGULATION; VIRUS INFECTION; VIRUS RECOMBINANT; ADENOVIRIDAE; BIOSYNTHESIS; BREAST NEOPLASMS; CELL CULTURE; CYTOTOXICITY; GENE VECTOR; GENETICS; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; SECRETION (PROCESS); TUMOR CELL LINE;

ADENOVIRIDAE;

ADENOVIRIDAE; ADULT; BREAST NEOPLASMS; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; MAMMAGLOBIN A; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84877051088     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063055     Document Type: Article

References (45)

1. He DD, Wang CF, Cao LL, Zhou J, Huang Jun, et al. (2010) Epidemic Trend of Female Breast Cancer Incidence in Min hang District, Shanghai. China Cancer 13: 108-10.
2. Gilboa E, (2007) DC-based cancer vaccines. J Clin Invest 117: 1195-203.
3. Peng W, Zhao G, Ma Y, Yu H, Wang X, (2011) Dendritic cells transfected with PEG10 recombinant adenovirus elicit anti-tumor immune response in vitro and in vivo. Vaccine 29: 3501-6.
4. Noh YW, Jang YS, Ahn KJ, Lim YT, Chung BH, (2011) Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response. Biomaterials 32: 6254-63.
5. Wierecky J, Mueller M, Brossart P, (2006) Dendritic cell-based cancer immunotherapy targeting MUC-1. Cancer Immunol Immunother 55: 63-7.
6. Ilias Basha H, Tiriveedhi V, Fleming TP, Gillanders WE, Mohanakumar T, (2011) Identification of immunodominant HLA-B7-restricted CD8+ cytotoxic T cell epitopes derived from mammaglobin-A expressed on human breast cancers. Breast Cancer Res Treat 127: 81-9.
7. Manna PP, Jaramillo A, Majumder K, Campbell LG, Fleming TP, et al. (2003) Generation of CD8+ cytotoxic T lymphocytes against breast cancer cells by stimulation with mammaglobin-A-pulsed dendritic cells. Breast Cancer Res Treat 79: 133-6.
8. Jaramillo A, Narayanan K, Campbell LG, Benshoff ND, Lybarger L, et al. (2004) Recognition of HLA-A2-restricted mammaglobin-A-derived epitopesby CD8+ cytotoxic T lymphocytes from breast cancer patients. Breast Cancer Res Treat 88: 29-41.
9. Wintermeyer P, Gehring S, Eken A, Wands JR, (2010) Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells. J Viral Hepat 17: 705-13.
10. Chen X, Yu Y, Pan Q, Tang Z, Han J, et al. (2008) Enhancement of cytotoxic T lymphocyte activity by dendritic cells loaded with Tat-protein transduction domain-fused hepatitis B virus core antigen. Acta Biochim Biophys Sin 40: 996-1004.
11. Chamoto K, Kosaka A, Tsuji T, Matsuzaki J, Sato T, et al. (2003) Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy. Cancer Sci 94: 924-8.
12. Yoon SH, Yun SO, Park JY, Won HY, Kim EK, et al. (2009) Selective addition of CXCR3+CCR4-CD4+ Th1 cells enhances generation of cytotoxic T cells by dendritic cells in vitro. Exp Mol Med 41: 161-70.
13. Miyazawa M, Iwahashi M, Ojima T, Katsuda M, Nakamura M, et al. (2011) Dendritic cells adenovirally-transduced with full-length mesothelin cDNA elicit mesothelin-specific cytotoxicity against pancreatic cancer cell lines in vitro. Cancer Lett 305: 32-9.
14. Garetto S, Sizzano F, Brusa D, Tizzani A, Malavasi F, et al. (2009) Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation. Cytotherapy 11: 1090-100.
15. Smits EL, Anguille S, Cools N, Berneman ZN, Van Tendeloo VF, (2009) Dendritic cellbased cancer gene therapy. Hum Gene Ther 20: 1106-18.
16. Watson MA, Fleming TP, (1994) Isolation of differentially expressed sequence tags from human breast cancer. Cancer Res 54: 4598-602.
17. Watson MA, Fleming TP, (1996) Mammaglobin, a mammary specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 56: 860-5.
18. Fleming TP, Watson MA, (2000) Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann N Y Acad Sci 923: 78-89.
19. Jin SJ, Huang Y, Liu GX, Sun XD, Tan Y, et al. (2010) hMAM mRNA expression and clinical significance. Bull Acad Mil Med Sci l34: 440-3.
20. Tian S, Liu Z, Donahue C, Noh HS, Falo LD Jr, et al. (2009) Transcriptional IL-15-Directed in vivo DC Targeting DNA Vaccine. Gene Ther 16: 1260-70.
21. Bernstein JL, Godbold JH, Raptis G, Watson MA, Levinson B, et al. (2005) Identification of Mammaglobin as a Novel Serum Marker for Breast Cancer. Clin Cancer Res 11: 6528-35.
22. Kim J, Jayaprakasha GK, Patil BS, (2013) Limonoids and their anti-proliferative and anti-aromatase properties in human breast cancer cells. Food Funct 4(2): 258-65.
23. Ceballos MP, Zumoffen C, Massa E, Cipulli G, Funes CC, et al. (2011) Detection of mammaglogin A in blood from breast cancer patients, before and after treatment, using a one-tube nested PCR protocol. Association with the absence of tumor estrogen receptors. Clin Biochem 44: 1429-33.
24. Mikhitarian K, Martin RH, Ruppel MB, Gillanders WE, Hoda R, et al. (2008) Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study. BMC Cancer 8: 55.
25. Al-Joudi FS, Kaid FA, Ishak I, Mohamed N, Osman K, et al. (2011) Expression of human mammaglobin and clinicopathologic correlations in breast cancer: The findings in Malaysia. Indian J Pathol Microbiol 54(2): 284-9.
26. Aline F, Brand D, Pierre J, Roingeard P, Séverine M, et al. (2009) Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination. Vaccine 27: 5284-91.
27. Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, et al. (1996) High level IL-12 production by murine dendritic cells up-regulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 184: 741-6.
28. Young JW, (1999) Dendritic cell: expansion and differentiation with hematopoietic growth factors. Curr Opin Hematol. 6(3): 135-44.
29. Micheva I, Thanopoulou E, Michalopoulou S, Karakantza M, Kouraklis-Symeonidis A, et al. (2004) Defective tumor necrosis factor alpha-induced maturation of monocyte-derived dendritic cells in patients with myelodysplastic syndromes. Clin Immunol 113(3): 310-7.
30. Chen B, Shi Y, Smith JD, Chol D, Geiger JD, et al. (1998) The role of tumor necrosis factor-a in modulating the quantity of peripheral blood-derived, cytokine driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to cd4+ t cells in vitro. Blood 91(12): 4652-61.
31. Hirata N, Yanagawa Y, Ogura H, Satoh M, Noguchi M, et al. (2011) The role of tumor necrosis factor-a for interleukin-10 production by murine dendritic cells. Cell immunol 266(2): 165-71.
32. Herrera OB, Brett S, Lechler RI, (2002) Infection of mouse bone marrow- derived cells with recombinant adenovirus vectors leads to presentation of eccoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design. Vaccine 21(3-4): 231-42.
33. Vujanovic L, Theresa L, Potter DM, Chu J, Ferrone S, et al. (2009) Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus. Cancer Immunol Immunother 58(1): 121-33.
34. Xie LH, Sin FW, Cheng SC, Cheung YK, Chan KT, et al. (2008) Activation of cytotoxic T lymphocytes against CML28-bearing tumors by dendritic cells transduced with a recombinant adeno-associated virus encoding the CML28 gene. Cancer Immunol Immunother 57: 1029-38.
35. Ge C, Xing Y, Wang Q, Xiao W, Lu Y, et al. (2011) Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432.Int Immunopharmacol. 11: 2200-7.
36. Hirschowitz EA, Weaver JD, Hidalgo GE, Doherty DE, (2000) Murine dentritic cells infected with adenovirus vectors show signs of activation. Gene therapy 7: 1112-20.
37. Philpott NJ, Nociari M, Elkon KB, Falck-Pedersen E, (2004) Adenovirus- induced maturation of dendritic cells through a PI3 kinase-mediated TNF-a induction pathway. Proc Natl Acad Sci U S A 101(16): 6200-5.
38. Morelli AE, Larregina AT, Ganster RW, Zahorchak AF, Plowey JM, et al. (2000) Recombinant adenovirus induces maturation of dendritic cells via an NF-KB-dependent pathway. J Virol 74(20): 9617-28.
39. Balwin AS Jr, (1995) The NF- n B and In B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-83.
40. Wu YG, Wu GZ, Wang L, Zhang YY, Li Z, et al. (2010) Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo. Med Oncol 27: 736-42.
41. Narayanan K, Jaramillo A, Benshoff ND, Campbell LG, Fleming TP, et al. (2004) Response of Established Human Breast Tumors to Vaccination with Mammaglobin-A cDNA. J Natl Cancer Inst 96: 1388-96.
42. Chen JH, Yu YS, Chen XH, Liu HH, Zang GQ, et al. (2012) Enhancement of CTLs induced by DCs loaded with ubiquitinated hepatitis B virus core antigen. World J Gastroenterol 18: 1319-27.
43. Li A, Xiong S, Lin Y, Liu R, Chu Y, (2011) A High-Affinity T-Helper Epitope Enhances Peptide-Pulsed Dendritic Cell-Based Vaccine. DNA Cell Biol 30: 883-92.
44. Tiriveedhi V, Sarma NJ, Subramanian V, Fleming TP, Gillanders WE, et al. (2012) Identification of HLA-A24- restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen. Hum Immunol 73: 11-6.
45. Wei CH, Uhlin M, Masucci MG, Levitsky V, (2002) Tetramer binding and secretion of interferon-a in response to antigenic stimulation are compatible with a range of affinities of MHC:TCR interaction and distinct programs of cytotoxic T-lymphocyte activation. Hum Immunol 63: 821-33.